• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Ascletis Announces Appointment of Mr. John P. Gargiulo as Chief Business Officer


Ascletis Pharma Inc. announced the expansion of management team with appointment of Mr. John P. Gargiulo. Gargiulo will lead Ascletis' corporate business development and alliance management in this new role and report to Dr. Jinzi J. Wu, PhD, Founder, Chairman and CEO of Ascletis.

Mr. John P. Gargiulo has over 30 years of successful experience in marketing strategies, business integration and commercial operations in global pharma/biotech industry.

"John is a veteran in our industry. His proven track record in business development and commercial operation will further strengthen our management team. We are very excited to have his on-board as Ascletis is advancing in the frontiers with a focus on viral diseases, NASH/PBC and oncology. Together with the collaborations we already built globally, this new appointment will further accelerate Ascletis' next stage of growth as we expect to launch multiple commercial products in the next three years," said Dr. Jinzi J. Wu, PhD, Founder, Chairman and CEO of Ascletis.

Related Videos
Related Content